Study of Genetic Risk Factors for Spina Bifida and Anencephaly (SBRR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00031122|
Recruitment Status : Unknown
Verified May 2009 by Office of Rare Diseases (ORD).
Recruitment status was: Active, not recruiting
First Posted : February 27, 2002
Last Update Posted : October 5, 2010
|Condition or disease||Intervention/treatment|
|Spina Bifida Anencephaly||Other: No Intervention|
The terms spina bifida and anencephaly include a range of developmental malformations that result from abnormal or incomplete closure of the neural tube. Despite advances in treatment and prenatal detection, these conditions remain as one of the most common and serious groups of birth defects. Spina bifida is associated with both increased mortality and morbidity, and anencephaly is always fatal. The occurrence of these conditions has a profound influence on affected individuals and their families and important public health implications. The etiology of NTDs has been of considerable interest for several decades. They are known to be etiologically heterogeneous and to occur in association with chromosome abnormalities, teratogenic exposures, and occasionally as part of single gene disorders. However, a specific causative agent cannot be identified in the vast majority of affected individuals. The etiology of NTDs in these "non-syndromic" patients is believed to be complex and to involve both genetic and environmental risk factors. Using a comprehensive research program, this study will evaluate the potential genetic determinants of SB and anencephaly in a large, well-characterized sample.
The family constellation used in this study consists of the proband (individual with an NTD - SB or A) and the proband's biologic parents and maternal grandparents. Blood or saliva samples are obtained from individuals and their families. Genomic DNA from all study participants is prepared from the samples, and genetic loci are evaluated. The proband, or his/her parents, complete a study questionnaire to obtain family history and epidemiologic information.
|Study Type :||Observational|
|Estimated Enrollment :||1100 participants|
|Official Title:||The Spina Bifida Research Resource|
|Study Start Date :||September 2000|
|Estimated Primary Completion Date :||September 2011|
|Estimated Study Completion Date :||September 2012|
Families with a child/pregnancy affected with spina bifida or anencephaly
Other: No Intervention
There is no intervention in this study
- Genetic loci identification and comparisons [ Time Frame: After DNA sampling ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00031122
|United States, Pennsylvania|
|The University of Pennsylvania School of Medicine|
|Philadelphia, Pennsylvania, United States, 19104|
|United States, Texas|
|The Texas A & M University Health Science Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Laura E. Mitchell, Ph.D.||The Texas A & M University Health Science Center|